Roche Holding AG's Fiscal Year is From January To December.
The item "Financial-Leverage-Ratio" stands at 3.25 as of 06/30/2025.
As of the end of Roche Holding AG's second quarter, the item "Financial Leverage Ratio" stands at 3.25. This represents a decrease of -0.08 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.72 percent compared to the value the year prior.
The 1 year change in percent is 1.72.
The 3 year change in percent is -9.77.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Financial Leverage Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Financial Leverage Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Financial Leverage Ratio | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Financial Leverage Ratio | 280,205,508,085.11 |
![]() | Novartis AG - Financial Leverage Ratio | 255,096,620,580.91 |